Research to improve genetic risk evaluation and management after diagnosis of cancer: IHPI Seminar

In this talk, from October 21, 2021, Steven Katz, M.D., M.P.H., Professor of Internal Medicine, and Elena Stoffel, M.D., M.P.H., Associate Professor, Gastroenterology & Hepatology, discuss work aimed at improving the use of genetic risk evaluation and management after a cancer diagnosis.

The speakers:
- Provide a primer on the growing role of genetic risk evaluation after diagnosis of cancer
- Discuss the challenges of incorporating genetic risk evaluation and management in patients after diagnosis of cancer and in families at high risk of hereditary cancer syndromes
- Describe two Beau Biden Moonshot cancer clinical trials led by Michigan faculty intended to increase patient and family members access to genetic risk evaluation and management and improve outcomes in the community

The talk was part of the Seminar series of the University of Michigan Institute for Healthcare Policy and Innovation - https://ihpi.umich.edu/